KFS
RMD icon

Keynote Financial Services’s ResMed RMD Stock Holding History

Keynote Financial Services’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Hold
1,215
– – 0.11% 161
2026
Q1 		$273K Hold
1,215
– – 0.15% 136
2025
Q4 		$293K Hold
1,215
– – 0.16% 131
2025
Q3 		$333K Sell
1,215
-90
-7% -$24.6K 0.2% 120
2025
Q2 		$337K Hold
1,305
– – 0.23% 113
2025
Q1 		$292K Hold
1,305
– – 0.21% 118
2024
Q4 		$298K Sell
1,305
-20
-2% -$4.82K 0.23% 113
2024
Q3 		$323K Hold
1,325
– – 0.25% 105
2024
Q2 		$254K Hold
1,325
– – 0.21% 114
2024
Q1 		$262K Buy
+1,325
New +$243K 0.22% 113

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Keynote Financial Services's RMD Position: Q2 2026 in Review

Keynote Financial Services held its ResMed (RMD) position steady in Q2 2026 at 1,215 shares worth $237K. The position accounts for 0.11% of the portfolio, ranked #161.

Keynote Financial Services first reported a position in RMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $337K in Q2 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Keynote Financial Services held 1,215 shares of ResMed worth $237K as of Q2 2026.
  • Keynote Financial Services left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.11% of Keynote Financial Services's portfolio in Q2 2026, its #161 holding.
  • Keynote Financial Services first reported a position in ResMed in Q1 2024 and has held it in 10 quarters since.
  • Keynote Financial Services's ResMed position peaked at $337K in Q2 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Keynote Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.